Nebius Group stock has a neutral daily setup with a defensive bias beneath its key exponential averages. Positive daily MACD evidence supports the bullish case, but hourly strength does not resolve the overhead resistance. Meanwhile, earnings coverage published on Thursday adds uncertainty that Wednesday’s completed charts do not capture.
Key takeaways
- NBIS closed Wednesday’s session at $154.69, a gain of 15.44% versus the previous close, on volume of 39,830,900 shares.
- The daily close sits below the 20-session EMA at $159.4, the 200-session EMA at $177.01, and the 50-session EMA at $184.23.
- Daily RSI14 is 45.58, below the neutral 50 threshold, while the daily MACD line is -17.71, above its signal at -18.25, with a positive histogram of 0.53.
- Hourly RSI14 is 64.27 and the hourly MACD line at 5.55 exceeds its signal at 3.53, with a positive histogram of 2.02.
- The next-session daily pivot is $154.09, with first resistance at $160.81 and first support at $147.96.
Nebius Group stock faces daily resistance
Nebius Group stock’s daily close sits below its key exponential averages, so the daily chart does not establish a bullish trend. The close sits below the 20-session EMA at $159.4, the 200-session EMA at $177.01, and the 50-session EMA at $184.23. These averages place resistance above price, although their ordering is not a fully bearish alignment.
However, daily RSI14 stands at 45.58, below the neutral 50 threshold. The daily MACD line is -17.71, above its signal at -18.25, with a positive histogram of 0.53. That combination is mixed: the MACD relationship favors bulls, while RSI sits below neutral.
The daily Bollinger mid-band at $156.59 is also above the close. Its lower and upper bands stand at $121.62 and $191.57, leaving price within the envelope but below its midpoint. Daily ATR14 increased to $17 from $16.29; the larger reading makes volatility important when assessing nearby levels.
Hourly strength meets short-term resistance
Hourly momentum favors bulls, but overhead resistance keeps the setup incomplete. The daily close sits above the hourly 20-period EMA at $146.13 and the 50-period EMA at $144.19. However, the hourly 200-period EMA at $172.93 sits overhead, so the shorter averages do not establish complete bullish alignment.
Hourly RSI14 is 64.27, above 50 but below overbought territory. The hourly MACD line at 5.55 exceeds its signal at 3.53, with a positive histogram of 2.02. These readings favor bulls on the hourly timeframe, in contrast with the daily chart’s below-neutral RSI. Price also sits above the hourly Bollinger mid-band at $144.27 and below the upper band at $164.12.
In contrast, the 15-minute chart offers less supportive execution context. The daily close lies below its 20-period EMA at $155.25 and lower Bollinger band at $154.79. It sits above the 50-period EMA at $149.19 and the 200-period EMA at $146.64. The 15-minute RSI14 is 55.89, but its MACD line at 2.51 is below the signal at 3.65. The negative histogram of -1.13 means immediate timing does not confirm the hourly bullish MACD relationship.
Thursday’s reports are separate from Wednesday’s session
Notably, Thursday, November 12 coverage came after Wednesday’s completed session, not during its trading. Seeking Alpha reported third-quarter revenue of $980.8 million, up 571.3%. The report also cited expected 2027 revenue of $12 billion–$13 billion and capital expenditure of $40 billion–$45 billion. Those reports cannot explain Wednesday’s gain, and the completed charts do not measure the subsequent reaction.
Bullish and bearish conditions for the next session
For the next session, Nebius Group stock stands above the daily pivot at $154.09 but below its daily mid-band and key exponential averages. First resistance sits at $160.81 and first support at $147.96. These reference levels are calculated from the completed daily candle and apply when trading resumes.
The bullish scenario requires holding the daily pivot at $154.09. Price then needs to clear the daily Bollinger mid-band at $156.59 and the 20-session EMA at $159.4. A break above daily first resistance at $160.81 would provide further price confirmation. Daily RSI above 50 would also strengthen agreement between the daily and hourly readings.
Conversely, a break below the daily pivot at $154.09 would undermine that constructive setup. Below it, daily first support at $147.96 precedes the session low at $147.36. A break beneath both would invalidate the bullish hold-and-clear scenario.
Overall, Nebius Group stock stands above the next-session daily pivot but below its daily mid-band and key exponential averages. Daily ATR14 at $17 keeps volatility central. The unresolved questions are whether price can clear that resistance and how Thursday’s reports affect the next session.
FAQ
Is Nebius Group stock above or below its key daily averages?
The daily close at $154.69 sits below the 20-session EMA at $159.4, the 200-session EMA at $177.01, and the 50-session EMA at $184.23, so the daily chart does not establish a bullish trend.
What are the key levels for the next session?
The daily pivot is $154.09, with first resistance at $160.81 and first support at $147.96. A bullish setup requires holding the pivot, then clearing the daily Bollinger mid-band at $156.59 and the 20-session EMA at $159.4.
Do the Thursday reports explain Wednesday’s gain?
No. The Thursday, November 12 coverage came after Wednesday’s completed session, not during its trading, so those reports cannot explain Wednesday’s gain.
What does the hourly chart show?
Hourly RSI14 is 64.27, above 50, and the hourly MACD line at 5.55 exceeds its signal at 3.53. The daily close also sits above the hourly 20-period EMA at $146.13 and the 50-period EMA at $144.19, but below the hourly 200-period EMA at $172.93.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.